Fertility Policy Watch (Japan): Japan’s public insurance coverage for fertility treatment appears linked to a record jump in multiple pregnancies, with 4,354 ART-related cases in 2023 (+36% vs 2022), raising renewed calls for single-embryo transfer to cut maternal and neonatal risks. Clinical Trials Governance (China): China issued an updated Good Clinical Practice guideline for drugs, effective Sept 1, tightening ethical and scientific conduct and adding stronger data governance and electronic data traceability requirements. Kidney Health (India): A study in ICMR’s Indian Journal of Medical Research flags Telangana as having the highest CKD mortality rate in India in 2023 (19.84 deaths per lakh), with type 2 diabetes cited as a major driver. Food Safety Alert (US/Global): FDA and CDC linked moringa leaf powder supplements to an ongoing multistate Salmonella outbreak, with many consumers reporting they took the products before falling ill. Wellness Industry (Malaysia): Malaysia’s Global Wellness Forum 2026 (June 23, Kuala Lumpur) spotlights next-gen nutraceutical trends, shifting focus toward product formats and sustained use. Tourism & Health Access (Cambodia): Cambodia’s four-month visa-free trial for Chinese visitors (up to 14 days) aims to boost arrivals—an indirect pressure point for public health systems as travel demand rises.